CRISPR Therapeutics
private_company
CRISPR Therapeutics
Switzerlandwww.crisprtx.com/
series-aseries-c-plusHealthcare & Life SciencesGenomics & Molecular Biologypharmaceutical-developmentsynthetic biologytherapeuticsgene-therapyaisynthetic-biology
2
Investments Tracked
About
CRISPR Therapeutics is focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company is applying this technology platform to research, develop and commercialize medicines for various diseases.
Explore CRISPR Therapeutics's full profile on Brouky
Portfolio companies, co-investors, AI match scores, and deal-flow signals — free with an account.